IL127649A0 - Use of oligosaccharides for neutralising e. coli toxins - Google Patents

Use of oligosaccharides for neutralising e. coli toxins

Info

Publication number
IL127649A0
IL127649A0 IL12764997A IL12764997A IL127649A0 IL 127649 A0 IL127649 A0 IL 127649A0 IL 12764997 A IL12764997 A IL 12764997A IL 12764997 A IL12764997 A IL 12764997A IL 127649 A0 IL127649 A0 IL 127649A0
Authority
IL
Israel
Prior art keywords
neutralising
oligosaccharides
coli toxins
toxins
coli
Prior art date
Application number
IL12764997A
Original Assignee
Synsorb Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/786,930 external-priority patent/US5849714A/en
Application filed by Synsorb Biotech Inc filed Critical Synsorb Biotech Inc
Publication of IL127649A0 publication Critical patent/IL127649A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Ceramic Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL12764997A 1996-06-21 1997-06-20 Use of oligosaccharides for neutralising e. coli toxins IL127649A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66900496A 1996-06-21 1996-06-21
US08/786,930 US5849714A (en) 1996-06-21 1997-01-23 Treatment of bacterial dysentery
PCT/CA1997/000436 WO1997049431A2 (en) 1996-06-21 1997-06-20 Use of oligosaccharides for neutralising e. coli toxins

Publications (1)

Publication Number Publication Date
IL127649A0 true IL127649A0 (en) 1999-10-28

Family

ID=27100040

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12764997A IL127649A0 (en) 1996-06-21 1997-06-20 Use of oligosaccharides for neutralising e. coli toxins

Country Status (5)

Country Link
EP (1) EP0914162A2 (en)
CN (1) CN1209752A (en)
AU (1) AU733712B2 (en)
IL (1) IL127649A0 (en)
WO (1) WO1997049431A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA991410B (en) * 1998-02-23 1999-10-06 Synsorb Biotech Inc Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compositions.
US6291435B1 (en) 1999-03-04 2001-09-18 The Governs Of The University Of Alberta Treatment of diarrhea caused by enteropathogenic Escherichia coli

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230736A1 (en) * 1982-08-18 1984-02-23 Herbert Prof. Dr. 8400 Regensburg Rupprecht ACTIVE SUBSTANCES BONDED TO SILICON DIOXIDE, METHOD FOR THEIR PRODUCTION AND THEIR USE
SE8406626D0 (en) * 1984-12-27 1984-12-27 Bio Carb Ab ASSOCIATION AND COMPOSITION OF THERAPEUTIC OR DIAGNOSTIC USE, AS APPLICABLE TO USE OF SUCH ASSOCIATION AND COMPOSITION OF THERAPEUTIC TREATMENT AND INSULATION OF SHIGATOXIN
IL83715A0 (en) * 1987-08-31 1988-01-31 Yeda Res & Dev Pharmaceutical anti-protozoal compositions
US5443832A (en) * 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
ATE198991T1 (en) * 1991-10-18 2001-02-15 Synsorb Biotech Inc TREATMENT OF BACTERIAL DYSENTERY
IL109519A (en) * 1994-05-03 1999-03-12 Yeda Res & Dev Vaccines for oral immunization against infecting agents

Also Published As

Publication number Publication date
AU3161697A (en) 1998-01-14
AU733712B2 (en) 2001-05-24
CN1209752A (en) 1999-03-03
WO1997049431A2 (en) 1997-12-31
EP0914162A2 (en) 1999-05-12
WO1997049431A3 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
EP0825096A3 (en) Body construction
AU3770697A (en) 2- and 2,5-substituted phenylketoenols
ZA973105B (en) Compounds and methods for the selective treatment of cancer and bacterial infections.
ZA974523B (en) Endoscopes.
ZA9711029B (en) Therapeutic agents.
ZA97631B (en) Migraine treatment.
ZA977948B (en) Process for the control of weeds.
EP0666539A3 (en) Cache control system.
AU3995297A (en) Wet-base, down-fired water heater
CY2445B1 (en) Antibacterial cephalosporins.
AU1471297A (en) Microbicides
ZA973209B (en) Therapeutic compounds.
ZA978640B (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
ZA974811B (en) Novel therapeutic compounds.
EP0685359A3 (en) Tiltable hand grip.
IL127649A0 (en) Use of oligosaccharides for neutralising e. coli toxins
PL334253A1 (en) Substituted pyrazol-3-yl benzazoles
AU3564597A (en) Transmitter-receiver pair
ZA963184B (en) Coupling means.
AU2384995A (en) Sliding binocular body
AU3607995A (en) Microbicides
AU4167297A (en) Use of mutated macrolide binding protein for the prevention of guhd
ZA9711655B (en) Zeolite SSZ-48.
AU2203597A (en) Fluid treatment arrangement
AU1237297A (en) D.C. isolation block